1. Home
  2. VRCA vs FTLF Comparison

VRCA vs FTLF Comparison

Compare VRCA & FTLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$3.79

Market Cap

88.0M

Sector

Health Care

ML Signal

HOLD

Logo FitLife Brands Inc.

FTLF

FitLife Brands Inc.

SELL

Current Price

$8.69

Market Cap

86.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
VRCA
FTLF
Founded
2013
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.0M
86.6M
IPO Year
2018
2006

Fundamental Metrics

Financial Performance
Metric
VRCA
FTLF
Price
$3.79
$8.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
2
Target Price
$13.83
★ $17.50
AVG Volume (30 Days)
★ 45.3K
11.1K
Earning Date
11-13-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.37
Revenue
★ $35,577,000.00
$21,744,000.00
Revenue This Year
N/A
$30.00
Revenue Next Year
$58.01
$6.35
P/E Ratio
★ N/A
$23.18
Revenue Growth
★ 370.22
11.52
52 Week Low
$3.28
$8.50
52 Week High
$9.82
$19.95

Technical Indicators

Market Signals
Indicator
VRCA
FTLF
Relative Strength Index (RSI) 35.23 36.54
Support Level N/A N/A
Resistance Level $5.94 $9.74
Average True Range (ATR) 0.35 0.39
MACD -0.05 -0.02
Stochastic Oscillator 19.48 5.73

Price Performance

Historical Comparison
VRCA
FTLF

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

About FTLF FitLife Brands Inc.

FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Dr. Tobias, MusclePharm, Irwin Naturals, Applied Nutrition, Isatori, and Nature's Secret brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.

Share on Social Networks: